The heatmap showed that enriched pathways and MAN2B1 expression shared the same trend, thus suggesting that immune-related activation is involved in the glioma progression and influenced the prognosis of glioma patients (Figures 7A, B). The gene discussed is MAN2B1; the disease is glioma.